Ginkgo Bioworks Holdings (DNA) Prepaid Assets (2020 - 2026)
Ginkgo Bioworks Holdings posted quarterly Prepaid Assets of $16.2 million for Q1 2026, down 20.6% year-on-year from $20.4 million in Q1 2025, and down 34.98% on a QoQ basis from $25.0 million in Q4 2025.
Ginkgo Bioworks Holdings (DNA) has 7 years of Prepaid Assets data on file, last reported at $16.2 million in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets fell 20.6% year-over-year to $16.2 million; the trailing twelve-month figure through Mar 2026 stood at $16.2 million (down 20.6% YoY), and the FY2025 full-year result was $25.0 million, up 33.29% from the prior year.
- Prepaid Assets for Q1 2026 stood at $16.2 million, down from $25.0 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $51.8 million in Q4 2022 and bottomed at $16.2 million in Q1 2026.
- The 5-year median for Prepaid Assets is $33.1 million (2022), against an average of $31.5 million.
- The widest annual swing landed in 2022, when Prepaid Assets surged 4066.48%; it then sank 52.92% in 2024.
- A 5-year view of Prepaid Assets shows it stood at $51.8 million in 2022, then slipped by 23.24% to $39.8 million in 2023, then tumbled by 52.92% to $18.7 million in 2024, then soared by 33.29% to $25.0 million in 2025, then plunged by 34.98% to $16.2 million in 2026.
- The last three Prepaid Assets figures came in at $16.2 million (Q1 2026), $25.0 million (Q4 2025), and $21.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Ginkgo Bioworks Holdings | 542.03 Mn | 542.03 Mn | 16.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.23 Mn |
| Dec 31, 2025 | 24.96 Mn |
| Sep 30, 2025 | 21.86 Mn |
| Jun 30, 2025 | 26.21 Mn |
| Mar 31, 2025 | 20.44 Mn |
| Dec 31, 2024 | 18.73 Mn |
| Sep 30, 2024 | 22.32 Mn |
| Jun 30, 2024 | 34.10 Mn |
| Mar 31, 2024 | 38.02 Mn |
| Dec 31, 2023 | 39.78 Mn |
| Sep 30, 2023 | 29.39 Mn |
| Jun 30, 2023 | 48.36 Mn |
| Mar 31, 2023 | 33.87 Mn |
| Dec 31, 2022 | 51.82 Mn |
| Sep 30, 2022 | 37.78 Mn |
| Jun 30, 2022 | 38.72 Mn |
| Mar 31, 2022 | 33.09 Mn |
| Dec 31, 2021 | 9.74 Mn |
| Sep 30, 2021 | 17.31 Mn |
| Jun 30, 2021 | 929,250.00 |
| Mar 31, 2021 | 1.07 Mn |
| Dec 31, 2020 | 21.10 Mn |